Asset Strategy Leader, R&D Aesthetics
Core
Matrix leader accountable for an asset from discovery to end of life cycle, guiding comprehensive asset and brand strategies for development, registration, manufacture, and commercialization.
Role type
Senior IC asset strategy leader (pharmaceuticals/biotech)
Builds
Integrated cross-functional Global Asset Strategy and Brand Strategy for aesthetic device assets
Domain
Pharmaceuticals/Biotech, Aesthetics (facial aesthetics), Drug Development & Commercialization
Deliverable
production ML models | product features | dashboards & analysis | research | client delivery | infrastructure | physical/clinical work
Required skills
Strategic thinking, cross-functional leadership, enterprise-level planning, Go/No-Go decision making, competitive landscape analysis, regulatory strategy alignment, commercialization lifecycle management, stakeholder influence, budget management, team coaching
Preferred skills
Doctoral-level or MBA degree, 10+ years experience, experience in facial aesthetics device programs, experience following a single asset through all development and commercialization phases
Technologies
None stated
Responsibilities
Chair Asset Strategy Team (AST) and serve as primary point of contact for Pipeline Governance; Create and gain endorsement of integrated Global Asset Strategy and Brand Strategy; Analyze emerging data to drive recommendations and mitigate risks; Collaborate with AST functions to ensure program resourcing and alignment with Target Product Profile (TPP); Validate program viability from scientific and commercial perspectives; Establish ties with external parties for regulatory and advisory board interactions; Coach and mentor team members within the High Performing Teams (HPT) model.
Seniority
Senior, hands-on IC with enterprise-level thinking